NCT04000061Recruiting
Heart Failure-USB: Prediction and Progression
Source: ClinicalTrials.gov · Last updated 22 Sept 2026
Brief summary (registry, in English)
This retrospective cohort study is to identify triggers of heart failure (HF) development and drivers of HF progression as well as the underlying cardiac disease (phenotype) to identify patients at risk and predict the clinical course of the disease. Data of patients who were hospitalized during the years 2010-2023 with acute coronary syndrome (ACS) and/ or with acute heart failure (AHF) will be collected and analyzed. In a subgroup cohort efficacy and safety of digoxin in patients with acute heart failure triggered by tachyarrhythmia will be evaluated.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 6000 (estimated)
- First submitted
- 25 Jun 2019
- Start date
- 13 Jun 2019
- Primary completion date
- 4 Apr 2027
- Lead sponsor
- University Hospital, Basel, Switzerland
- Diseases
- Heart failure, Coronary artery disease
- NCT number
- NCT04000061
What you commit to
- Study type: Observational
- Planned participants: 6000
- From 13 Jun 2019 to the primary completion date, 4 Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Existence of a documented statement of the patient against the scientific use of clinical data
Who the study is looking for
- Patients hospitalized with a primary diagnosis of ACS
- Patients hospitalized with a primary or secondary diagnosis of AHF
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cardiology, University Hospital Basel Coordinator of this site? Confirm its status | Basel | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.